Skip to main content
. 2018 Mar 7;46(4):1634–1639. doi: 10.1177/0300060518760955

Table 1.

Serum amyloid A and C-reactive protein levels in patients with diffuse systemic sclerosis and healthy controls.

Serum amyloid A (mg/mL)
Serum C-reactive protein (mg/mL)
Median LQ UQ dSSc subgroup versus controls
Median LQ UQ dSSc subgroup versus controls
p-value Z-score p-value Z-score
dSSc (n = 33) 67.4 44.8 74.7 0.00013 3.8 47.7 12.8 197.6 0.00004 4.1
Early dSSc (n = 18) 69.9 44.9 76.5 0.0004 3.5283 74.3 19.6 224.5 0.0003 3.5957
Late dSSc (n = 15) 65.2 42.2 70.1 0.0013 3.2178 19.6 12.2 92.6 0.0002 3.7108
dSSc with ILD (n = 12) 74.6 64.2 77.9 0.0005 3.4773 159.8 67.3 339.3 0.0005 3.4773
dSSc without ILD (n = 21) 56.7 36.8 70.3 0.0009 3.3328 18.8 11.0 84.7 0.0002 3.7692
Controls (n = 11) 21.4 6.8 28.7 2.5 1.7 28.7

dSSc, diffuse systemic sclerosis; ILD, interstitial lung disease; LQ, lower quartile; UQ, upper quartile.